Loading clinical trials...
Loading clinical trials...
Phase II-b Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus Crispatus CTV-05 (LACTIN-V) to Prevent the Recurrence of Bacterial Vaginosis
Conditions
Interventions
Lactobacillus crispatus CTV-05
Metronidazole
+1 more
Locations
4
United States
University of California, San Diego - Antiviral Research Center
San Diego, California, United States
San Francisco General Hospital - Infectious Diseases
San Francisco, California, United States
Cook County Health and Hospitals System - Ruth M Rothstein CORE Center
Chicago, Illinois, United States
Washington University School of Medicine in St. Louis - Infectious Disease Clinical Research Unit
St Louis, Missouri, United States
Start Date
June 3, 2016
Primary Completion Date
February 11, 2019
Completion Date
February 11, 2019
Last Updated
March 4, 2020
NCT07394777
NCT06472765
NCT06469164
NCT06470906
NCT06123299
NCT02432404
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions